Cogent Biosciences, Inc. COGT Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period net of tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period net of tax?
- Cogent Biosciences, Inc. (COGT) reported other comprehensive income unrealized holding gain loss on securities arising during period net of tax of -$770K in Q1 2026.
- How has Cogent Biosciences, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period net of tax changed year-over-year?
- Cogent Biosciences, Inc.'s other comprehensive income unrealized holding gain loss on securities arising during period net of tax decreased by 172.1% year-over-year, from -$283K to -$770K.
- What does other comprehensive income unrealized holding gain loss on securities arising during period net of tax mean?
- This metric captures the change in the market value of investment securities held by the company that have not yet been sold. It represents paper gains or losses resulting from market price volatility rather than realized transactions. Tracking this helps investors understand the impact of market conditions on the company's treasury and investment portfolio.